RecruitingNot applicableNCT06113237

Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy

Studying Hydatidiform mole

Last synced from ClinicalTrials.gov March 21, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Jazz Pharmaceuticals
Principal Investigator: Clinical Trial Disclosure & Transparency
Intervention: Epidiolex(drug)
Eligibility: FEMALE
Timeline: 2025 – 2033

Study locations (1)

United Biosource LLC, Morgantown, West Virginia, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06113237 on ClinicalTrials.gov

Other trials for Hydatidiform mole

Additional recruiting or active studies for the same condition.

ENROLLING BY INVITATIONNANCT05872022
A Study to Evaluate Safety of Exposure to Wegovy During Pregnancy
Novo Nordisk A/S
ACTIVE NOT RECRUITINGNCT05516810
The Accuracy of Ultrasound Diagnosis of Hydatidiform Moles
King's College Hospital NHS Trust
RECRUITINGNANCT03785574
Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule
Women's Hospital School Of Medicine Zhejiang University
ACTIVE NOT RECRUITINGNCT01008501
Study of the Genetic and Epigenetic Causes of Recurrent Hydatidiform Moles
Baylor College of Medicine

See all trials for Hydatidiform mole →

← Back to all trials